CORIELL INSTITUTE FOR MEDICAL RESEARCH INC

Programs
Coriell Institute Research Programs
CORIELL INSTITUTE FOR MEDICAL RESEARCH, FOUNDED IN 1953 AND BASED IN CAMDEN, NEW JERSEY, IS AN INDEPENDENT NON-PROFIT RESEARCH INSTITUTE DEDICATED TO THE STUDY OF THE HUMAN GENOME. EXPERT STAFF AND PIONEERING PROGRAMS IN THE FIELDS OF PERSONALIZED MEDICINE, CELL BIOLOGY, CYTOGENETICS, GENOTYPING, AND BIOBANKING DRIVE OUR MISSION. THE INSTITUTE MAINTAINS REPOSITORIES FOR CELL LINES AND DNA AND DISTRIBUTES OVER 20,000 BIOMATERIALS ANNUALLY TO RESEARCHERS NATIONALLY AND INTERNATIONALLY.CORIELL HAS A DISTINGUISHED HISTORY IN CELL BIOLOGY, PURSUING CURRENTLY INDUCED PLURIPOTENT STEM (IPS) CELL RESEARCH. THESE POWERFUL CELLS ARE REVOLUTIONIZING THE WAY HUMAN DISEASE IS STUDIED AND HOW DRUGS ARE DEVELOPED. CORIELL OFFERS CUSTOM RESEARCH SERVICES INCLUDING CELL CULTURE, CYTOGENETIC ANALYSES, AND MOLECULAR BIOLOGY. ITS CLIA-CERTIFIED GENOTYPING AND MICROARRAY CENTER OFFERS HIGH-THROUGHPUT DNA ANALYSIS SYSTEMS USING THE PLATFORMS OF TWO LEADING PROVIDERS.ESSENTIAL TO THE INSTITUTE'S SUPPORT OF INTERNATIONAL SCIENTIFIC RESEARCH IS THE CORIELL BIOBANK. FROM THIS RENOWNED CELL BANK, CORIELL MANAGES AND DISTRIBUTES THE WORLD'S MOST DIVERSE COLLECTION OF CELL LINES, DNA, AND OTHER BIOLOGICAL RESOURCES. THE CORIELL BIOBANK PROVIDED SUPPORT TO THE HUMAN GENOME PROJECT, A WORLDWIDE PROGRAM TO MAP THE ENTIRE HUMAN GENOME, AND TO THE INTERNATIONAL HAPMAP PROJECT, A PROJECT PROVIDING AN EFFICIENT TOOL TO IDENTIFY DISEASE-CAUSING GENES.CORIELL'S BIOBANKING OPERATION IS FUNDED BY SEVERAL NATIONAL INSTITUTE OF HEALTH AWARDS.GeographiesNot indicatedDatesJul 1, 2020 – Jun 30, 2021Source990No causes providedNo populations provided–$11.8MProgram 1 [2024]
THE CORIELL INSTITUTE FOR MEDICAL RESEARCH IS A GLOBALLY RECOGNIZED LEADER IN BIOBANKING AND BIOMEDICAL RESEARCH. CORIELL IS HOME TO ONE OF THE WORLD'S MOST IMPORTANT BIOBANKS WHICH DISTRIBUTES BIOLOGICAL SAMPLES AND OFFERS RESEARCH AND BIOBANKING SERVICES TO SCIENTISTS AROUND THE WORLD. CORIELL IS THE TRUSTED STEWARD OF WORLD-RENOWNED COLLECTIONS FOR THE NATIONAL INSTITUTES OF HEALTH, DISEASE FOUNDATIONS AND COMMERCIAL CLIENTS. IN ADDITION, AS A LEADER IN GENOMIC AND EPIGENOMIC RESEARCH, CORIELL IS UNCOVERING WAYS OR GENETIC MAKEUP AFFECTS OUR HEALTH, ESPECIALLY IN REGARD TO CANCER AND AGING.GeographiesNot indicatedDatesJul 1, 2023 – Jun 30, 2024Source990No causes providedNo populations provided–$18.6MProgram 2 [2024]
ON MARCH 1, 2023, THE INSTITUTE ENTERED INTO AN AGREEMENT WITH ROWAN UNIVERSITY, OF NEW JERSEY (ROWAN) AND THE COOPER HEALTH SYSTEM (COOPER), TO CREATE, COLLECTIVELY, THE CAMDEN CANCER RESEARCH CENTER (THE CENTER). THE AGREEMENT IS INTENDED TO CREATE A COLLABORATIVE JOINT VENTURE AMONG CAMDEN BASED INSTITUTIONS TO FURTHER EFFORTS TO FIND NEW TREATMENTS AND IMPROVE CURE RATES FOR CANCER PATIENTS, BOTH IN THE COMMUNITIES PRIMARILY SERVED BY THE CENTER AND FOR THE GENERAL PUBLIC AT LARGE. ADDITIONALLY, THE CENTER INTENDS TO DEVELOP THE INFRASTRUCTURE AND RESEARCH INITIATIVES THAT WILL ENABLE THE CENTER TO OBTAIN NATIONAL CANCER INSTITUTE (NCI) CONSORTIUM DESIGNATION IN COLLABORATION WITH ONE OR MORE NCI DESIGNATED CANCER CENTERS.GeographiesNot indicatedDatesJul 1, 2023 – Jun 30, 2024Source990No causes providedNo populations provided–$191.2K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)